Grass City 20% OFF

CORAL GABLES, FL / ACCESSWIRE / November 28, 2018 / Marijuana stocks are once again in the spotlight after a brief hiatus during previous weeks. Following Canada’s legalization announcement, many cannabis stocks pulled back (along with the entire stock market) but recent developments after US Midterms have pot stocks back on watch.

News that Congress was close to finishing the new farm bill added to the excitement. The bill is poised to include provisions to legalize hemp . Senator Patty Murray tweeted, ”Passing a bipartisan #FarmBill is important to WA families, from helping put food on the table, to supporting our farmers and fruit growers, to promoting conservation.”

In addition, New Jersey recently hit its stride as of Monday morning following Thanksgiving when lawmakers stated that they are moving toward the legalization of cannabis in the near future. So as more legislation comes in place, here are 4 marijuana stocks to look at this quarter.

Premier Health Group, Inc. (OTC:PHGRF) (CNSX:PHGI.CN) announced an update on its plan to expand the scope of practice within its primary care clinics to include cannabis.

Premier Health Group, Inc. (OTC:PHGRF) (CNSX:PHGI.CN) has engaged discussions with Licensed Producers under the Access to Cannabis for Medical Purposes Regulation, other licensed medical cannabis companies, and government officials in order to establish a framework for both patient and physician education.

”With over 110,000 active patients in our clinic ecosystem, it is important that we provide them with the best possible information that allows them to make informed decisions about their personal and family’s health. Providing our family physicians with the appropriate tools and knowledge to prescribe cannabis or with the ability to refer patients to a specialist within our clinics is a key outcome of this initiative,” said Dr. Essam Hamza, CEO of Premier.

The Canadian medical cannabis clinic market is estimated to be worth approximately $2.35 billion by 2025. With this in mind, the company said that it expects to provide additional updates on acquisitions in Q4-18 and Q1-19.

“Cannabis clinics fit in perfectly with our existing Telemedicine services and comprehensive app plans. The patient will not only be able to see their family doctor with our app but also connect with their Cannabis clinic healthcare worker, the education nurse and eventually even the pharmacy or LP that is providing the prescription. This team-based and encompassing approach will provide the best and most convenient care for our patients,” said Dr. Hamza in a previous release.

Premier Health Group, Inc. (OTC:PHGRF) (CNSX:PHGI.CN) is focused on developing innovative health care approaches that combine human skill based expertise with emerging technologies, and will set the gold standard for services in locations of interest worldwide. HealthVue, Premier Health’s subsidiary, is focused on developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence.

For More Information On Premier Health Group, Click Here

Aurora Cannabis (NYSE:ACB) announced this morning that the company, through a selling broker, has completed the sale in the open market of the Australis Capital Inc. units on behalf of non-resident shareholders. Payment of the net cash proceeds from the sales of Australis units to the non-resident shareholders of record as of August 24, 2018 was completed by the custodian on November 27, 2018 . In total, 11,222,349 units of Australis were sold in the public markets.

The Company originally completed the spin out of its U.S. assets through the distribution of Australis units to Canadian resident shareholders on September 19, 2018.

“With this final distribution of net cash proceeds to non-resident shareholders, Aurora has completed its commitment to return capital to all of our shareholders,” said Terry Booth , CEO of Aurora. “Since its public listing, the team at Australis have hit the ground running, executing on a number of investments with strong growth potential. Through our contingent interest in Australis, we’ll keep a close eye on the exciting U.S. market, and look to exercise our back-in right as soon as federal regulations permit.”

This news comes on the heels of Aurora recent announcement that the company has received an export request, has secured the required export permit and has now completed its first shipment of medical cannabis products to the Czech Republic, making this the 21st country in which the company operates.

For More Information On Aurora, Click Here

Tilray (NASDAQ:TLRY) has some expecting near term volatility from the stock. According to reports from Zacks, ”Investors in Tilray, Inc. TLRY need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 30, 2018 $130.00 Call had some of the highest implied volatility of all equity options.”

Tilray recently reported earnings including an adjusted loss per share of 8 cents, better than a loss of 12 cents expected by four analysts polled by Refinitiv. Its total revenue came in at $10 million, an 85.8 percent increase over the last year. Tilray CEO Brendan Kennedy was quick to point out to in a CNBC interview that this revenue was all tied to medical, not adult use.

“All of that revenue for this quarter is medical and we look forward to next quarter, when we’ll start to see some Canadian adult-use revenue in that earnings report,” Kennedy said.

Tilray announced earlier in the third quarter that it had become the first and only company to receive regulatory approval in Canada and Germany to export medical cannabis flower for distribution to German patients.

For More Information On Tilray, Click Here

New Age Beverages (NBEV) recently announced the closing of its previously announced underwritten public offering of 12,900,000 shares of New Age’s common stock, at a price of $3.50 per share, plus an additional 1,935,000 shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters.

New Age Beverages estimates net proceeds from the offering to be approximately $49 million, after deducting underwriting discounts and estimated offering expenses. The Company intends to use the net proceeds from this offering for potential acquisitions.

These results helped to boost shares of the company earlier this month. On Tuesday, NBEV traded as high as $3.77 during the regular session.

In addition to this, the company announced the results for the third quarter ended September 30, 2018 this month. For the three-month period ended September 30, 2018, gross revenues reached $15.3 million versus $16.8 million in the prior year quarter. Net revenues less discounts, returns and billbacks reached $13.2 million versus $15.0 in the prior-year quarter.

Shares were up as high as $3.77 during premarket trading on Wednesday.

For More Information On New Age, Click Here

About is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

MAPH Enterprises LLC, which owns, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of, MIDAM VENTURES, LLC and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam was paid $100,000 (CASH) for & were paid “500,000” shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the “500,000” shares of Premier Health Group Inc. that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. As of November 26, 2018 member of MAPH holds 40,000 shares and 800 $7.50 call options of Aurora Cannabis purchased in the open market, which may be sold at any time. Our disclaimers will update at such time. Please click here for full disclaimer

Contact Information:


Stock Symbols